New Parkinson’s Drug Targets Disease at Genetic Level
Summary of Breakthrough Parkinson’s Drug Targets Disease at Its Genetic Roots: A new experimental treatment, BIIB094, targeting the LRRK2 gene, shows promise in lowering LRRK2 protein levels in a clinical…